Sequential CD19 and CD22 chimeric antigen receptor T-cell therapy for childhood refractory or relapsed B-cell acute lymphocytic leukaemia: a single-arm, phase 2 study.

Autor: Pan, Jing1 (AUTHOR) panj@gobroadhealthcare.com, Tang, Kaiting1,2,3 (AUTHOR), Luo, Yuechen1,2,3 (AUTHOR), Seery, Samuel4 (AUTHOR), Tan, Yue2,3 (AUTHOR), Deng, Biping5 (AUTHOR), Liu, Feng6 (AUTHOR), Xu, Xiuwen6 (AUTHOR), Ling, Zhuojun7 (AUTHOR), Song, Weiliang7 (AUTHOR), Xu, Jinlong7 (AUTHOR), Duan, Jiajia7 (AUTHOR), Wang, Zelin7 (AUTHOR), Li, Chunyu7 (AUTHOR), Wang, Kai7 (AUTHOR), Zhang, Yibing2,3 (AUTHOR), Yu, Xinjian6 (AUTHOR), Zheng, Qinlong6 (AUTHOR), Zhao, Liping2,3 (AUTHOR), Zhang, Jiecheng8 (AUTHOR)
Zdroj: Lancet Oncology. Nov2023, Vol. 24 Issue 11, p1229-1241. 13p.
Databáze: Academic Search Ultimate